J. Tauscher

发表

Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.

Alan A. Wilson, S. Kapur, S. Houle, 2002, Archives of general psychiatry.

Test–Retest Reproducibility of Binding Parameters in Humans with 11C-LY2795050, an Antagonist PET Radiotracer for the κ Opioid Receptor

Richard E. Carson, Nabeel Nabulsi, Shu-Fei Lin, 2015, The Journal of Nuclear Medicine.

[Neuroimaging in substance abuse disorders].

S. Kasper, J. Tauscher, A. de Mendelssohn, 2004, Der Nervenarzt.

11C-LY2428703, a positron emission tomographic radioligand for the metabotropic glutamate receptor 1, is unsuitable for imaging in monkey and human brains

E. Nisenbaum, P. Zanotti-Fregonara, S. Zoghbi, 2013, EJNMMI Research.

S. Hunt, D. Hommer, D. Economidou, 2009, Alcohol.

Evaluation in vitro and in animals of a new 11C-labeled PET radioligand for metabotropic glutamate receptors 1 in brain

E. Nisenbaum, P. Zanotti-Fregonara, S. Zoghbi, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study

D. Mikulis, B. Christensen, R. Zipursky, 2002, Schizophrenia Research.

A new algorithm for treating schizophrenia.

I. Glick, D. Pickar, T. Suppes, 1998, Psychopharmacology bulletin.

Quetiapine: efficacy and tolerability in schizophrenia

S. Kasper, J. Tauscher, A. Heiden, 2001, European Neuropsychopharmacology.

Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance

S. Kasper, L. Pezawas, B. Küfferle, 2000, International clinical psychopharmacology.

Previous treatment as a confounding variable in studies with novel antipsychotics: two cases of high dopamine-2 receptor occupancy with quetiapine

S. Kasper, B. Küfferle, S. Asenbaum, 1997, Psychopharmacology.

Exploratory analyses of regional human brain distribution of the PET tau tracer F18-labeled T807 (AV-1541) in subjects with normal cognitive function or cognitive impairment thought to be due to Alzheimer's disease

M. Mintun, A. Joshi, M. Pontecorvo, 2013, Alzheimer's & Dementia.

Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia

S. Kasper, L. Pezawas, B. Küfferle, 1999, European Archives of Psychiatry and Clinical Neuroscience.

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol

S. Kasper, B. Küfferle, S. Asenbaum, 1997, Psychopharmacology.

63-2 Sertindole and dopamine D2 receptor occupancy

S. Kasper, B. Küfferle, S. Asenbaum, 1997, Biological Psychiatry.

P.2.069 123I IBZM spect imaging of dopamine-2 receptors in psychotic patients treated with zotepine

S. Kasper, B. Küfferle, S. Asenbaum, 1997, European Neuropsychopharmacology.

IBZM-SPECT imaging of dopamine D2 receptors with typical and atypical antipsychotics

S. Kasper, T. Brücke, J. Tauscher, 1998, European Psychiatry.

P-4-32 IBZM-SPECT and D2 dopamine receptor occupancy: Different profiles with atypical neuroleptics

S. Kasper, B. Küfferle, S. Asenbaum, 1995, European Neuropsychopharmacology.

IBZM-SPECT imaging of dopamine D(2) receptors with typical and atypical antipsychotics.

S. Kasper, T. Brücke, J. Tauscher, 1998, European psychiatry : the journal of the Association of European Psychiatrists.

Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder

G. Marek, S. Iyengar, F. Vandenhende, 2010, European Neuropsychopharmacology.

Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [11C]PHNO PET

A. Schwarz, J. Passchier, G. Searle, 2021, Neuropsychopharmacology.

Inverse Relation Between Stimulus Intensity and Seizure Duration: Implications for ECT Procedure

S. Kasper, R. Frey, P. Felleiter, 2001, The journal of ECT.

Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: a [(11)C]WAY-100635 PET investigation in healthy volunteers.

J Tauscher, S Kasper, S. Kapur, 2001, The American journal of psychiatry.

Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2

B. Gulyás, C. Halldin, A. Varrone, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: A PET study in nonhuman primate brain using ( S , S )-[18F]FMeNER-D2

B. Gulyás, C. Halldin, R. Innis, 2006, NeuroImage.

A Risk-Benefit Assessment of Mirtazapine in the Treatment of Depression

S. Kasper, N. Praschak-Rieder, J. Tauscher, 1997, Drug safety.

224. D2 — Receptor imaging (SPECT) as a tool for measuring the efficacy and side-effect profile of treatment with neuroleptics

S. Kasper, A. Neumeister, S. Asenbaum, 1996, Biological Psychiatry.

123I.-@3-CIT SPECT:Binding Kinetics and Effects of Normal Aging

N. Praschak-Rieder, A. Neumeister, S. Asenbaum, 2000 .

Receptor Occupancy of the k-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer

Yiyun Huang, R. Carson, J. Ropchan, 2016 .

Evaluation of an inverse agonist with high affinity for the CB1 receptor, [11C]MePPEP, in rodents and humans

Garth E. Terry, C. Halldin, S. Zoghbi, 2008, NeuroImage.

Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder

Wolfgang Wadsak, Markus Mitterhauser, Christoph Spindelegger, 2007, Biological Psychiatry.

Maintenance treatment in depression: the role of pharmacological and psychological treatment

S. Kasper, D. Winkler, J. Tauscher, 2002 .

Striatal D2 receptor occupancy in bipolar patients treated with olanzapine

J. Sacher, S. Kasper, N. Mossaheb, 2007, European Neuropsychopharmacology.

Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography.

Robert B. Innis, Victor W. Pike, Johannes T. Tauscher, 2011, Journal of medicinal chemistry.

Relationship between Power Spectra of the Awake EEG and Psychomotor Activity Patterns Measured by Short-Term Actigraphy

D. Winkler, O. Presslich, S. Kasper, 2003, Neuropsychobiology.

No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism

Kurt Hornik, Alexander Neumeister, Siegfried Kasper, 2001, Biological Psychiatry.

Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2

Johannes T. Tauscher, Christer Halldin, Per Karlsson, 2008, NeuroImage.

Is the Combination of ADOS and ADI-R Necessary to Classify ASD? Rethinking the “Gold Standard” in Diagnosing ASD

V. Roessner, L. Poustka, D. Heider, 2021, Frontiers in Psychiatry.

Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents

Jeih-San Liow, Christer Halldin, Garth E. Terry, 2008, NeuroImage.

Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder

S. Kasper, A. Konstantinidis, D. Winkler, 2002, European Neuropsychopharmacology.

Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.

J Tauscher, N. Praschak-Rieder, A. Neumeister, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism

Ariel B. Lindner, Miroslav Radman, S. Hunt, 2008, Science.

The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain

Christer Halldin, Fumihiko Yasuno, Eyassu Chernet, 2008, Neuropsychopharmacology.

[123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder

Alexander Neumeister, Siegfried Kasper, Oliver Vitouch, 2000, Biological Psychiatry.

Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol

S. Kasper, B. Küfferle, S. Asenbaum, 2002, Psychopharmacology.

Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder

S. Kasper, A. Konstantinidis, M. Willeit, 2002, European Neuropsychopharmacology.

Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study

B. Gulyás, C. Halldin, A. Varrone, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study

Rupert Lanzenberger, Christoph Spindelegger, Siegfried Kasper, 2007, Psychopharmacology.

In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram

R. Lanzenberger, J. Sacher, S. Kasper, 2006, Psychopharmacology.

Dopamine depletion results in increased neostriatal D2, but not D1, receptor binding in humans

J Tauscher, S. Kapur, S. Houle, 2002, Molecular Psychiatry.

Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.

Alan A. Wilson, S. Kapur, G. Remington, 2004, The American journal of psychiatry.

Choosing the Right Dose of Antipsychotics in Schizophrenia

S. Kapur, J. Tauscher, 2001, CNS drugs.

Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.

Adam J Schwarz, Peng Yu, E. Siemers, 2012, Journal of Alzheimer's disease : JAD.

Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography

Jeih-San Liow, Cheryl L. Morse, Robert B. Innis, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand

Jeih-San Liow, Cheryl L. Morse, Robert B. Innis, 2009, NeuroImage.

Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.

S. Kapur, B. Christensen, R. Zipursky, 2002, The Journal of clinical psychiatry.

A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT2A receptor changes in schizophrenia

Shitij Kapur, Jeffrey H. Meyer, S. Kapur, 2000, Psychiatry Research: Neuroimaging.

[123I] β-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa

S. Kasper, N. Praschak-Rieder, A. Neumeister, 2001, Biological Psychiatry.

[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.

J Tauscher, S Kasper, S. Kasper, 2000, Biological psychiatry.

The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development

Dean F Wong, Gerhard Gründer, Johannes Tauscher, 2009, Neuropsychopharmacology.

Significant dissociation of brain and plasma kinetics with antipsychotics

J Tauscher, S. Kapur, G. Remington, 2002, Molecular Psychiatry.

Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans

Cheryl L. Morse, Robert B. Innis, Victor W. Pike, 2014, NeuroImage.

Brain and Whole-Body Imaging of Nociceptin/Orphanin FQ Peptide Receptor in Humans Using the PET Ligand 11C-NOP-1A

Talakad G. Lohith, Sami S Zoghbi, Victor W Pike, 2012, The Journal of Nuclear Medicine.

Imaging and Quantitation of Cannabinoid CB1 Receptors in Human and Monkey Brains Using 18F-Labeled Inverse Agonist Radioligands

Jeih-San Liow, Cheryl L. Morse, Robert B. Innis, 2010, Journal of Nuclear Medicine.

Receptor and Transporter Imaging Studies in Schizophrenia, Depression, Bulimia and Tourette's Disorder—Implications for Psychopharmacology-

Ivo Podreka, Alexander Neumeister, Siegfried Kasper, 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Serotonin 5-HT1A Receptor Binding Potential Declines with Age as Measured by [11C]WAY-100635 and PET

Shitij Kapur, Siegfried Kasper, Johannes Tauscher, 2001, Neuropsychopharmacology.

Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2

B. Gulyás, C. Halldin, R. Innis, 2006, NeuroImage.

Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.

G. Heinze, J. Sacher, S. Kasper, 2007, The international journal of neuropsychopharmacology.

Therapy of Treatment Resistant Depression: Focus on the Management of TRD with Atypical Antipsychotics

J. Sacher, S. Kasper, J. Tauscher, 2004, CNS Spectrums.

In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment

S. Kasper, M. Zwaan, S. Asenbaum, 1999, European Neuropsychopharmacology.

Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation.

S. Kasper, N. Praschak-Rieder, A. Neumeister, 1998, Archives of general psychiatry.

Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients

Peter Rappelsberger, Alexander Neumeister, Siegfried Kasper, 1998, Biological Psychiatry.

Kinetic Modeling of 11C-LY2795050, A Novel Antagonist Radiotracer for PET Imaging of the Kappa Opioid Receptor in Humans

Richard E Carson, Nabeel Nabulsi, Shu-Fei Lin, 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Volumetric MRI measurement of caudate nuclei in antipsychotic-naive patients suffering from a first episode of psychosis.

D. Mikulis, B. Christensen, R. Zipursky, 2005, Journal of psychiatric research.

Identification of the most indicative and discriminative features from diagnostic instruments for children with autism

V. Roessner, L. Poustka, D. Heider, 2021, JCPP advances.

Extrapyramidal symptoms with atypical antipsychotics: A [123i]IBZM SPECT study

B. Küfferle, S. Asenbaum, J. Tauscher, 2002, European Neuropsychopharmacology.

Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol – a 123I-IBZM SPECT study

S. Kasper, B. Küfferle, S. Asenbaum, 1998, Psychopharmacology.

Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone

S. Kasper, B. Küfferle, S. Asenbaum, 1996, Psychiatry Research: Neuroimaging.

In vivo 123I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients

S. Kasper, B. Küfferle, M. Willeit, 2001, Psychopharmacology.